mu-Opiate receptor agonists -- a new pharmacological approach to prevent motion sickness?

Br J Clin Pharmacol. 2006 Jan;61(1):27-30. doi: 10.1111/j.1365-2125.2005.02505.x.

Abstract

Aims: Stress hormones might be involved in motion sickness. The influence of loperamide on kinetosis-induced nausea and stress hormone release was investigated in a placebo-controlled, cross-over study.

Methods: Standardized rotation around the vertical axis combined with head movements was used to induce nausea 3 h after 16 mg loperamide or placebo (n = 8). Plasma antidiuretic hormone (ADH), adrenocorticotropic hormone (ACTH) and nausea ratings were investigated.

Results: After loperamide nausea was significantly lower (P < 0.02). ACTH (P < 0.05) and ADH levels (P < 0.02) increased significantly in both settings, but were lower after loperamide.

Conclusions: The susceptibility to develop kinetosis-induced nausea and stress hormone release is decreased by loperamide, although the site of action remains speculative.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Adult
  • Cross-Over Studies
  • Female
  • Humans
  • Loperamide / administration & dosage*
  • Male
  • Motion Sickness / prevention & control*
  • Nausea / prevention & control*
  • Receptors, Opioid, mu / agonists*
  • Rotation
  • Single-Blind Method
  • Vasopressins / blood

Substances

  • Receptors, Opioid, mu
  • Vasopressins
  • Loperamide
  • Adrenocorticotropic Hormone